Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response

被引：0
|
作者：
Mai, Nicholas
Safonov, Anton
Marra, Antonio
Chen, Yuan
Chandarlapaty, Sarat
Razavi, Pedram
Plitas, George
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] European Inst Oncol IRCCS, Div Early Drug Dev, Milan, Italy
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
    Schrock, A. B.
    Ouyang, C.
    Sandhu, J.
    Sokol, E.
    Jin, D.
    Ross, J. S.
    Miller, A.
    Lim, D.
    Amanam, I
    Chao, J.
    Catenacci, D.
    Cho, M.
    Braiteh, F.
    Klempner, S. J.
    Ali, S. M.
    Fakih, M.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1096 - 1103
  • [2] Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition
    Zang, Peter D.
    Chawla, Neal S.
    Barragan-Carrillo, Regina
    Chehrazi-Raffle, Alex
    Tripathi, Abhishek
    Pal, Sumanta K.
    Dorff, Tanya B.
    JAMA ONCOLOGY, 2024, 10 (04) : 531 - 532
  • [3] Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma
    Andrews, Miles C.
    Li, Gerald
    Graf, Ryon P.
    Fisher, Virginia A.
    Mitchell, Jerry
    Aboosaiedi, Ali
    O'Rourke, Harriet
    Shackleton, Mark
    Iddawela, Mahesh
    Oxnard, Geoffrey R.
    Huang, Richard S. P.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [4] Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma
    Andrews, Miles C.
    Li, Gerald
    Graf, Ryon P.
    Fisher, Virginia A.
    Mitchell, Jerry
    Aboosaiedi, Ali
    O'Rourke, Harriet
    Shackleton, Mark
    Iddawela, Mahesh
    Oxnard, Geoffrey R.
    Huang, Richard S. P.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [5] Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness
    Quintanilha, Julia C. F.
    Storandt, Michael H.
    Graf, Ryon P.
    Li, Gerald
    Keller, Rachel
    Lin, Douglas I.
    Ross, Jeffrey S.
    Huang, Richard S. P.
    Schrock, Alexa B.
    Oxnard, Geoffrey R.
    Chakrabarti, Sakti
    Mahipal, Amit
    JCO PRECISION ONCOLOGY, 2023, 7
  • [6] Utility of Tumor Mutational Burden as a Biomarker for Response to Immune Checkpoint Inhibition in the VA Population
    Scobie, Micaela R.
    Zhou, Katherine I.
    Ahmed, Sara
    Kelley, Michael J.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [7] RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN PATIENTS WITH MICROSATELLITE INSTABLE AND HIGH TUMOR MUTATIONAL BURDEN PROSTATE CANCER
    Lenis, Andrew T.
    Ravichandran, Vignesh
    Hong Truong
    Reisz, Peter
    Nweji, Barbara
    Autio, Karen
    Morris, Michael
    Slovin, Susan
    Vargas, Hebert Alberto
    Laudone, Vincent
    Ehdaie, Behfar
    Reuter, Victor
    Viale, Agnes
    Schultz, Nikolaus
    Gopalan, Anuradha
    Donoghue, Mark
    Stopsack, Konrad
    Solit, David
    Abida, Wassim
    JOURNAL OF UROLOGY, 2021, 206 : E411 - E411
  • [8] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
    Qian, Xiaoyan
    Tao, Yunxia
    Chen, Haizhu
    Li, Xin
    Wang, Yaqin
    Xu, Xiaoming
    Li, Shuo
    Chen, Haoyu
    Cang, Shundong
    Liu, Yang
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [9] Clinical, pathologic, and molecular associations of tumor mutational burden in metastatic breast cancer
    Mohamed, Mohamed A.
    Wang, Chenghuang
    Buckley, Morgan
    Lehman, Jennifer
    Canzoniero, Jenna
    Gocke, Christopher D.
    Nunes, Raquel
    Park, Ben Ho
    Smith, Karen L.
    Tao, Jessica
    Tukachinsky, Hanna
    Wilkinson, Mary
    Wolff, Antonio C.
    Stearns, Vered
    Santa-Maria, Cesar A.
    CANCER RESEARCH, 2022, 82 (04)
  • [10] Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer
    Lenis, Andrew T.
    Ravichandran, Vignesh
    Brown, Samantha
    Alam, Syed M.
    Katims, Andrew
    Truong, Hong
    Reisz, Peter A.
    Vasselman, Samantha
    Nweji, Barbara
    Autio, Karen A.
    Morris, Michael J.
    Slovin, Susan F.
    Rathkopf, Dana
    Danila, Daniel
    Woo, Sungmin
    Vargas, Hebert A.
    Laudone, Vincent P.
    Ehdaie, Behfar
    Reuter, Victor
    Arcila, Maria
    Berger, Michael F.
    Viale, Agnes
    Scher, Howard I.
    Schultz, Nikolaus
    Gopalan, Anuradha
    Donoghue, Mark T. A.
    Ostrovnaya, Irina
    Stopsack, Konrad H.
    Solit, David B.
    Abida, Wassim
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3894 - 3903
12345